Tuesday, January 1, 2019

Cipla Q2 FY19 Earnings Conference Call

Cipla Q2 FY19 Earnings Conference Call This is the verbatim transcript of Cipla management call with analysts.

from Moneycontrol Business News http://bit.ly/2GLXUm0

No comments:

Post a Comment

Zaynich's blockbuster potential lifts Wockhardt's long-term outlook

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years o...